We are one of the few firms well-positioned to handle the unique and often complicated aspects of trials and post-grant proceedings before the United States Patent and Trademark Office (USPTO).
Our dedicated team of patent attorneys and paralegals have extensive experience that allow us to successfully manage and resolve Inter Partes Reviews (IPRs), Covered Business Method patent reviews (CBMs), Post Grant Reviews (PGRs), patent interferences, and derivation proceedings—from initial review by the USPTO Patent Trial and Appeal Board (PTAB) through final hearing by the US Court of Appeals for the Federal Circuit. Indeed, our USPTO-registered attorneys are involved in all aspects of inter partes proceedings. We regularly develop strategies that help our clients both invoke and/or avoid those proceedings, using our vitally important litigation skills and deep technical understanding to proactively establish a strong position that, in many cases, prevents long and costly opposition. In the past two decades, we have handled some 30 patent interferences. And since the enactment of the America Invents Act (AIA) in September 2012, we have handled nearly 85 IPRs and CBMs, making us one of the top firms actively engaged in this practice area.
Our expertise spans a wide range of technical disciplines, including molecular biology, genetics, semiconductor processing, computer software, and medical devices. We also stand ready to help our clients leverage the broad patent law changes introduced by the AIA—including the replacement of traditional inter partes reexaminations with new proceedings that more closely resemble litigation. Several of our attorneys served on USPTO committees that developed rules for these proceedings, giving us an intimate knowledge of the changes, and positioning us to provide the highest level of representation in the USPTO's new proceedings.